Paying peer reviewers works.
Expanded Fast & Fair experiment @biologyopen.bsky.social:
• 5.5 vs 37.7 working days to decision with reviews
• ~3 vs ~9 reviewer invitations per manuscript
• no reduction in editor-assessed review quality
• similar acceptance rates
www.biorxiv.org/content/10.6...
Clinical development of gene edited tacrolimus-resistant Treg (FKBP12KO-Treg) to enable simultaneous immunosuppression and support of immune regulation https://www.biorxiv.org/content/10.64898/2025.12.10.693159v1
Together with @ronghuizhu.bsky.social, we are thrilled to present our new perturb-seq study of 22M primary CD4+ T cells, across donors and timepoints – the result of a decade-long collaboration between the Marson @marsonlab.bsky.social and Pritchard @jkpritch.bsky.social labs 🧵 tinyurl.com/gwt2025
Rotation PhD student @emiliedevet.bsky.social in our lab made the Dish soap protocol work (on the first attempt) for a nuclear target with Dawn (the US version of dreft/fairy ) and thereby extended the dish soap protocol to a version for across the atlantic 🤩 @tothovalab.bsky.social #hemesky
🚨This week in @natcomms.nature.com: We resolve an enduring enigma in T cell biology—how TCR binding to p/HLA triggers intracellular signaling. CryoEM in native environment reveals a 'jack-in-the-box' mechanism! Collab btw
@rockefeller.edu @mskcancercenter.bsky.social
rdcu.be/eUPPl
Terrific to have our paper, led by @tjflemin.bsky.social, featured as a plenary article in @bloodjournal.bsky.social today: ashpublications.org/blood/articl...
Come see our presidential keynote presentation from FOCIS President Ignacio Anegon in Salon 8! 📣📣
#Focis2026
🚨 Don’t miss the upcoming joint FOCIS & IUIS Virtual Symposium
💡 Immune-Mediated Inflammatory Diseases, New Mechanisms, and Therapeutic Options
📆 Thursday, May 7, 2026 | 4:00 - 5:30 PM (London); 10:00 - 11:30 AM (Chicago)
Register now: zurl.co/7MGet
Original work here ⬇️, led by the inimitable Lorenzo Brunetti and Michael Gundry. This work became foundational in the field.
Distinct EBV-Associated Phenotypes Due to a Novel Homozygous Missense Variant in CD27. https://www.biorxiv.org/content/10.64898/2026.01.15.698722v1
